At the beginning, companies and research projects typically attract investment based on historical performance and a promising future. Continuation of funding, however, is usually contingent upon meeting milestones that build value. This panel will help you identify the “right” milestones.  In addition, we’ll explore:

• The relationship among technical, financial and organizational milestones
• Strategies for balancing competing priorities
  
• How milestones and the commercialization model evolve over time
• Why total dollars spent doesn’t necessarily equal an investor’s valuation

Our panel includes a life sciences investor, seasoned entrepreneur, intellectual property attorney and expert in organization growth, and will be moderated by an advisor to life sciences startups with deep life sciences expertise. Please join our experts and your colleagues on September 29^th, either live or remotely.